FDA approves 18F-florbetapir PET agent.
D000544:Alzheimer Disease / Q000000981:diagnostic imaging*; D000814:Aniline Compounds; D017277:Drug Approval; D005026:Ethylene Glycols; D049268:Positron-Emission Tomography; D014481:United States; D014486:United States Food and Drug Administration
D000814:Aniline Compounds; D005026:Ethylene Glycols; C545186:florbetapir